c-RAF ablation induces regression of advanced Kras/Trp53 mutant lung adenocarcinomas by a mechanism independent of MAPK signaling

Cited by (120)

Items 101–120 of 120

1. Partners in Crime: Clandestine Operations among RAS-RAF Accomplices in Promoting Tumorigenesis
   Avinashnarayan Venkatanarayan, Shiva Malek · 2019 · Molecular Cell
2. Inhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC
   Rafael Rosell, Niki Karachaliou, Carles Codony, Masaoki Ito · 2018 · Translational Lung Cancer Research
3. Explorando a quinase IKK como um alvo terapêutico para células iniciadoras de tumor pulmonares induzidas pelo oncogene KRAS
   Felipe Silva Rodrigues · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
4. Mechanistic insight into sex differences in lung cancer induced by cRaf
   Shen Zhong, Jürgen T. Borlak · 2023 · Research Square
5. Data from Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition
   Liang Yan, Bo Tu, Jun Yao, Jing Gong, Alessandro Carugo, Christopher Aaron Bristow, Qiuyun Wang, Cihui Zhu, Bingbing Dai, Ya’an Kang et al. · 2023
6. Supplementary Figure from Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition
   Liang Yan, Bo Tu, Jun Yao, Jing Gong, Alessandro Carugo, Christopher Aaron Bristow, Qiuyun Wang, Cihui Zhu, Bingbing Dai, Ya’an Kang et al. · 2023
7. Target Hyperactive ERK Signaling for Cancer Therapy
   Jiajun Yap, Jiancheng Hu · 2023 · Springer eBooks
8. Failed reprogramming of transformed cells due to induction of apoptosis and senescence impairs tumor progression in lung cancer
   Pablo Pedrosa, Zhenguang Zhang, David Macías, Jianfeng Ge, Mary Denholm, Anna Dyas, Victor Nuñez-Quintela, Valentín Estévez‐Souto, Patricia Lado‐Fernández, Patricia Gonzalez et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
9. Mitochondrial Raf1 Regulates Glutamine Catabolism
   Ronald L. Shanderson, Ian Ferguson, Zurab Siprashvili, Luca Ducoli, Albert Mao Li, Weili Miao, Suhas Srinivasan, Mary Grace M. Velasco, Yang Li, Jiangbin Ye et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
10. Bioluminescence Resonance Energy Transfer (BRET)-based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
    Russell Spencer-Smith · 2024 · Journal of Visualized Experiments
11. RAS Family Interactions: The SHOC2-MRAS-PP1 Complex in Noonan Syndrome
    Isabel Boned del Río, Pablo Rodriguez‐Viciana · 2024 · Springer eBooks
12. A BAG-1-inhibitory peptide, GO-Pep, suppresses c-Raf activity in cancer
    Özge Tatlı, Ecenur Cebi, Miray Türk, Baran Dingiloğlu, Aycan Sezan, Ezgi Basturk, Betül Zehra Temur, Alp Ertunga Eyüpoğlu, Berna Bicak, Esra Erdal et al. · 2025 · Communications Biology
13. Target Hyperactive ERK Signaling for Cancer Therapy
    Jiajun Yap, Jiancheng Hu · 2025 · Springer eBooks
14. Discovery of potent KRASG12D inhibitors disrupting RAS-Raf interaction to block activation
    Zhaoyang Li, Junru Liu, Yingying Yan, Xiujuan Shi, Benlong Cao, Y. Lynn Wang, Fuxun Huang, Jingtong Feng, Qingqiang Yao, Bo Liu et al. · 2026 · Results in Chemistry
15. Unraveling the Impact of KRAS Accessory Proteins on Oncogenic Signaling Pathways
    Vanshika Garg, Raphael N. H. M. Hofmann, Moazzam Saleem, Amin Mirzaiebadizi, Ghazaleh sadat hashemi, Tooba Hameed, Bahareh Jooyeh, Silke Pudewell, Mehrnaz Mehrabipour, Niloufar Mosaddeghzadeh et al. · 2026 · Cells
16. Une nouvelle stratégie thérapeutique pour prolonger la réponse du cancer bronchique aux inhibiteurs d’EGFR en prévenant l’émergence des cellules résistantes
    Lisa Brunet · 2021 · theses.fr (ABES)
17. RAF1 scaffold integrity shapes chemogenetic degradation outcomes in KRAS-driven lung cancer
    Laura de la Puente Ovejero, Ana Domostegui, Inés María García-Pérez, Gonzalo Aizpurua, Lucia Lomba-Riego, Pilar Ximénez‐Embún, Cristina Mayor‐Ruiz, Mariano Barbacid, Sara García‐Alonso · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
18. Mitochondrial Raf1 regulates glutamine catabolism
    Ronald L. Shanderson, Ian Ferguson, Luca Ducoli, Weili Miao, Suhas Srinivasan, Zurab Siprashvili, Albert Mao Li, Mary Grace M. Velasco, Yang Li, Christine N. Hoang et al. · 2026 · Cell Reports
19. RAF1 scaffold integrity shapes chemogenetic degradation outcomes in KRAS-driven lung cancer models
    Laura de la Puente Ovejero, Ana Domostegui, Inés María García-Pérez, Gonzalo Aizpurua, Lucia Lomba-Riego, Pilar Ximénez‐Embún, Cristina Mayor‐Ruiz, Mariano Barbacid, Sara García‐Alonso · 2026 · Life Science Alliance
20. BindingDB Entry 50013756: Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors.
    BindingDB · 2022 · UC San Diego